Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Jun;74(6):710–714. doi: 10.1136/jnnp.74.6.710

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles

A Riazi 1, J Hobart 1, D Lamping 1, R Fitzpatrick 1, J Freeman 1, C Jenkinson 1, V Peto 1, A Thompson 1
PMCID: PMC1738466  PMID: 12754336

Abstract

Objective: To examine the relative impact of two chronic neurological disorders, multiple sclerosis and Parkinson's disease, by comparing patients' scores on the medical outcomes study 36-item short form health survey (SF-36) with the health profile of the United Kingdom population norms.

Methods: 638 people representing the full spectrum of multiple sclerosis and 227 patients with Parkinson's disease were studied. Health status was measured by the SF-36. Scores for the eight health domains were compared after controlling for age, sex, disease duration, mobility, social class, ethnicity, education, marital status, and employment status.

Results: People with multiple sclerosis and those with Parkinson's disease had significantly worse health than the general population on all eight domains measured by the SF-36. The relative impact of multiple sclerosis and Parkinson's disease were similar, but multiple sclerosis resulted in poorer scores on physical functioning and better scores in mental health. People with mild multiple sclerosis who walked without an aid also had significantly worse scores in all dimensions than the general UK population.

Conclusions: The results highlight the need for further research into aspects of health measured by the SF-36. Nevertheless, generic measures that are applicable across multiple diseases may fail to address clinically important aspects of the impact of specific disorders.

Full Text

The Full Text of this article is available as a PDF (161.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowling A., Bond M., Jenkinson C., Lamping D. L. Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey. J Public Health Med. 1999 Sep;21(3):255–270. doi: 10.1093/pubmed/21.3.255. [DOI] [PubMed] [Google Scholar]
  2. Chrischilles E. A., Rubenstein L. M., Voelker M. D., Wallace R. B., Rodnitzky R. L. The health burdens of Parkinson's disease. Mov Disord. 1998 May;13(3):406–413. doi: 10.1002/mds.870130306. [DOI] [PubMed] [Google Scholar]
  3. Feinstein A., Feinstein K. Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Disord. 2001 Oct;66(2-3):193–198. doi: 10.1016/s0165-0327(00)00298-6. [DOI] [PubMed] [Google Scholar]
  4. Ford H. L., Gerry E., Johnson M. H., Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil. 2001 Aug 15;23(12):516–521. doi: 10.1080/09638280010022090. [DOI] [PubMed] [Google Scholar]
  5. Freeman J. A., Hobart J. C., Langdon D. W., Thompson A. J. Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):150–156. doi: 10.1136/jnnp.68.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hermann B. P., Vickrey B., Hays R. D., Cramer J., Devinsky O., Meador K., Perrine K., Myers L. W., Ellison G. W. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res. 1996 Oct;25(2):113–118. doi: 10.1016/0920-1211(96)00024-1. [DOI] [PubMed] [Google Scholar]
  7. Hobart J., Lamping D., Fitzpatrick R., Riazi A., Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001 May;124(Pt 5):962–973. doi: 10.1093/brain/124.5.962. [DOI] [PubMed] [Google Scholar]
  8. Hobson P., Meara J. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the Short-Form 36 and the Parkinson's Disease Questionnaire. Age Ageing. 1996 Jul;25(4):334–335. doi: 10.1093/ageing/25.4.334-b. [DOI] [PubMed] [Google Scholar]
  9. Jenkinson C., Peto V., Fitzpatrick R., Greenhall R., Hyman N. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39) Age Ageing. 1995 Nov;24(6):505–509. doi: 10.1093/ageing/24.6.505. [DOI] [PubMed] [Google Scholar]
  10. Kuopio A. M., Marttila R. J., Helenius H., Toivonen M., Rinne U. K. The quality of life in Parkinson's disease. Mov Disord. 2000 Mar;15(2):216–223. doi: 10.1002/1531-8257(200003)15:2<216::aid-mds1003>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  11. Nortvedt M. W., Riise T., Myhr K. M., Nyland H. I. Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care. 2000 Oct;38(10):1022–1028. doi: 10.1097/00005650-200010000-00006. [DOI] [PubMed] [Google Scholar]
  12. Nortvedt M. W., Riise T., Myhr K. M., Nyland H. I. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 1999 Sep 22;53(5):1098–1103. doi: 10.1212/wnl.53.5.1098. [DOI] [PubMed] [Google Scholar]
  13. Patten S. B., Metz L. M. Depression in multiple sclerosis. Psychother Psychosom. 1997;66(6):286–292. doi: 10.1159/000289150. [DOI] [PubMed] [Google Scholar]
  14. Rothwell P. M., McDowell Z., Wong C. K., Dorman P. J. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997 May 31;314(7094):1580–1583. doi: 10.1136/bmj.314.7094.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schrag A., Jahanshahi M., Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000 Nov;15(6):1112–1118. doi: 10.1002/1531-8257(200011)15:6<1112::aid-mds1008>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  16. Sprangers M. A., de Regt E. B., Andries F., van Agt H. M., Bijl R. V., de Boer J. B., Foets M., Hoeymans N., Jacobs A. E., Kempen G. I. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000 Sep;53(9):895–907. doi: 10.1016/s0895-4356(00)00204-3. [DOI] [PubMed] [Google Scholar]
  17. Thompson A. J., Montalban X., Barkhof F., Brochet B., Filippi M., Miller D. H., Polman C. H., Stevenson V. L., McDonald W. I. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol. 2000 Jun;47(6):831–835. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES